NCT00262795

Brief Summary

RATIONALE: Drugs used in chemotherapy, such as fludarabine and chlorambucil, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. It is not yet known whether fludarabine is more effective than chlorambucil in treating chronic lymphocytic leukemia. PURPOSE: This randomized phase III trial is studying fludarabine to see how well it works as first-line therapy compared to chlorambucil in treating older patients with previously untreated chronic lymphocytic leukemia.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
206

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Sep 2003

Geographic Reach
2 countries

88 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2003

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2005

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2005

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 6, 2005

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 7, 2005

Completed
Last Updated

May 23, 2019

Status Verified

May 1, 2019

Enrollment Period

1.3 years

First QC Date

December 6, 2005

Last Update Submit

May 21, 2019

Conditions

Keywords

stage 0 chronic lymphocytic leukemiastage I chronic lymphocytic leukemiastage II chronic lymphocytic leukemiastage III chronic lymphocytic leukemiastage IV chronic lymphocytic leukemia

Study Arms (2)

F

EXPERIMENTAL

Fludarabine

Drug: Fludarabine

CLB

ACTIVE COMPARATOR

Chlorambucil

Drug: Chlorambucil

Interventions

Fludarabine i.v. (25 mg/m2/d, d1-5) q28d; max 6 cycles

F

Chlorambucil p.o. (0,4 mg - max. 0,8 mg/kg/d, d1) q15d, max. 12 month

CLB

Eligibility Criteria

Age65 Years - 79 Years
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
DISEASE CHARACTERISTICS: * Confirmed diagnosis of chronic lymphocytic leukemia, meeting any of the following staging criteria: * Binet stage A with B symptoms * Binet stage B or C, meeting 1 of the following criteria: * Rapid disease progression * Enlarged lymph nodes and organs * Severe B symptoms * Previously untreated disease PATIENT CHARACTERISTICS: Performance status * ECOG 0-2 Life expectancy * More than 6 months Hematopoietic * No thrombocytopenia * No autoimmune hemolytic anemia Hepatic * Not specified Renal * Not specified Other * No severe organ dysfunction * No other prior or concurrent neoplasm PRIOR CONCURRENT THERAPY: Chemotherapy * No prior chemotherapy * No other concurrent chemotherapy

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (88)

Hanuschkrankenhaus

Vienna, A-1140, Austria

Location

Klinikum St. Marien

Amberg, D-92224, Germany

Location

Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie

Ansbach, 91522, Germany

Location

Zentralklinikum Augsburg

Augsburg, DOH-86156, Germany

Location

Humaine - Clinic

Bad Saarow, 15526, Germany

Location

Krankenhaus Hohe Warte Mediziniche Klinik

Bayreuth, 95445, Germany

Location

Onkologisches Versorgungszentrum Friedrichshain

Berlin, 10249, Germany

Location

Internistische Gemeinschaftspraxis - Berlin

Berlin, 14195, Germany

Location

Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin

Berlin, D-12200, Germany

Location

Charite - Campus Virchow Klinikum

Berlin, D-13353, Germany

Location

Saint Josef - Hospital Bochum

Bochum, 44791, Germany

Location

Praxis Dres. F.& G. Doering

Bremen, 28205, Germany

Location

Medizinische Universitaetsklinik I at the University of Cologne

Cologne, D-50924, Germany

Location

Onkologische Schwerpunktpraxis

Cottbus, D-03046, Germany

Location

Onkologische Gemeinschaftspraxis - Dresden

Dresden, 01127, Germany

Location

Krankenhaus Benrath

Düsseldorf, 40593, Germany

Location

Hans - Susemihl - Krankenhaus

Emden, D-26721, Germany

Location

Kreiskrankenhaus Erding

Erding, 85435, Germany

Location

Internistische/Onkologische Praxis - Erfurt

Erfurt, 99084, Germany

Location

Helios Klinikum Erfurt

Erfurt, 99089, Germany

Location

Onkologische Schwerpunkt Praxis

Erlangen, D-91052, Germany

Location

Universitaetsklinikum Essen

Essen, D-45122, Germany

Location

Evangelisches Krankenhaus Essen Werden

Essen, D-45239, Germany

Location

Gemeinschaftspraxis - Freiburg

Freiburg im Breisgau, 79098, Germany

Location

Klinikum Garmisch - Partenkirchen

Garmisch-Partenkirchen, N 82467, Germany

Location

Gemeinschaftspraxis Innere Medizin Hämatologie/Onkologie - Gera

Gera, 07548, Germany

Location

Internistische Praxis - Gerlingen

Gerlingen, 70839, Germany

Location

Internistische Praxisgemeinschaft

Germering, 82110, Germany

Location

Universitaetsklinikum Goettingen

Göttingen, D-37075, Germany

Location

Internistisch-Haematologische Gemeinschaftspraxis - Gustrow

Güstrow, 18273, Germany

Location

Internistische Praxis - Halle

Halle, 06108, Germany

Location

Internistische Gemeinschaftspraxis - Halle

Halle, 06110, Germany

Location

Universitaetsklinikum Hamburg-Eppendorf

Hamburg, D-20246, Germany

Location

St. Marien-Hospital Hamm - Klinik Knappenstrasse

Hamm, D-59071, Germany

Location

Schwerpunktpraxis Haematologie/Onkologie - Hannover

Hanover, 30169, Germany

Location

Eichsfeld Klinikum gGmbH

Heiligenstadt, 37339, Germany

Location

Medizinischen Klinik Dr. R. Schindlbeck

Herrsching am Ammersee, 82211, Germany

Location

Oncological Specialist Practice

Hildesheim, 31134, Germany

Location

Universitaetsklinikum des Saarlandes

Homburg, D-66421, Germany

Location

Clinic for Bone Marrow Transplantation and Hematology and Oncology

Idar-Oberstein, D-55743, Germany

Location

Westpfalz-Klinikum GmbH

Kaiserslautern, D-67653, Germany

Location

Staedt Klinikum Karlsruhe GGMBH

Karlsruhe, 76133, Germany

Location

Internistische Gemeinschaftspraxis - Kassel

Kassel, 34117, Germany

Location

Staedtische Krankenhaus Kiel

Kiel, 23116, Germany

Location

Krankenhaus Maria-Hilf Krefeld

Krefeld, 47805, Germany

Location

Internistische Onkologische Praxis - Kronach

Kronach, 96317, Germany

Location

Internistische Praxis - Landshut

Landshut, 84028, Germany

Location

Klinikum Lippe - Lemgo

Lemgo, D-32657, Germany

Location

Internistische Praxis - Ludwigsburg

Ludwigsburg, 71638, Germany

Location

Kreiskrankenhaus Luedenscheid

Lüdenscheid, 58515, Germany

Location

III Medizinische Klinik Mannheim

Mannheim, D-68305, Germany

Location

Regional Hospital Munchberg

Munchber, D-95213, Germany

Location

Klinikum Innenstadt

Munich, 80331, Germany

Location

Krankenhaus Muenchen Schwabing

Munich, 80804, Germany

Location

Hamatologische Schwerpunktpraxis

Munich, 81679, Germany

Location

Munich Oncologic Practice at Elisenhof

Munich, D-80335, Germany

Location

Klinikum der Universitaet Muenchen - Grosshadern Campus

Munich, D-81377, Germany

Location

Staedtisches Krankenhaus Muenchen - Harlaching

Munich, D-81545, Germany

Location

Klinikum Rechts Der Isar - Technische Universitaet Muenchen

Munich, D-81675, Germany

Location

Hamatologie/Onkologie Praxisgemeinschaft - Munchen

München, 81245, Germany

Location

Haematologisch-onkologische Gemeinschaftspraxis - Muenster

Münster, 48149, Germany

Location

Onkologische Schwerpunktpraxis Dr. Schmidt

Neunkirchen, D-66538, Germany

Location

Praxis fuer Haematologie und Interne Onkologie

Norderstedt, 22844, Germany

Location

Praxisklinik fuer Innere Medizin - Nuernberg

Nuremberg, 90449, Germany

Location

Klinikum Nuernberg - Klinikum Nord

Nuremberg, D-90419, Germany

Location

Internistische Gemeinschaftspraxis - Oberstaufen

Oberstaufen, 87534, Germany

Location

Internistische Gemeinschaftspraxis - Offenbach

Offenbach, 63065, Germany

Location

Internistische Gemeinschaftspraxis - Oldenburg

Oldenburg, 26121, Germany

Location

Klinikum Ernst Von Bergmann

Postdam, D-14467, Germany

Location

Haematologische/Onkologische Schwerpunktpraxis - Rostock

Rostock, 18057, Germany

Location

Klinik und Poliklinik fuer Innere Medizin - Universitaet Rostock

Rostock, D-18057, Germany

Location

Internistische Schwerpunktpraxis

Rüsselsheim am Main, 65428, Germany

Location

Schwerpunktpraxis Fuer Haematologie Und Onkologie

Saarbruecke, N-66113, Germany

Location

Internistische Gemeinschaftspraxis - Saarbruecken

Saarbrücken, 66121, Germany

Location

Caritasklinik St. Theresia

Saarbrücken, D-66113, Germany

Location

Kliniken Landkreis Sigmaringen GMBH

Sigmaringen, D-72488, Germany

Location

Internistische Gemeinschaftspraxis - Stuttgart

Stuttgart, 70176, Germany

Location

Marienhospital Stuttgart

Stuttgart, 70199, Germany

Location

Haematologische Praxis

Stuttgart, D-70173, Germany

Location

Klinik fuer Onkologie - Katharinenhospital Stuttgart

Stuttgart, D-70174, Germany

Location

Onkologische Gemeinschaftspraxis - Trier

Trier, 54290, Germany

Location

Krankenanstalt Mutterhaus der Borromaerinnen

Trier, D-54290, Germany

Location

Southwest German Cancer Center at Eberhard-Karls-University

Tübingen, D-72076, Germany

Location

Universitaetsklinikum Ulm

Ulm, D-89081, Germany

Location

St. Marien Hospital

Vechta, D-49377, Germany

Location

Gemeinschaftspraxis

Worms, DOH-67547, Germany

Location

Kliniken St. Antonius

Wuppertal, D-42283, Germany

Location

Hamatologisch - Onkologische Praxis Wurzburg

Würzburg, 97070, Germany

Location

Related Publications (5)

  • Eichhorst BF, Fischer K, Fink AM, Elter T, Wendtner CM, Goede V, Bergmann M, Stilgenbauer S, Hopfinger G, Ritgen M, Bahlo J, Busch R, Hallek M; German CLL Study Group (GCLLSG). Limited clinical relevance of imaging techniques in the follow-up of patients with advanced chronic lymphocytic leukemia: results of a meta-analysis. Blood. 2011 Feb 10;117(6):1817-21. doi: 10.1182/blood-2010-04-282228. Epub 2010 Dec 7.

    PMID: 21139079BACKGROUND
  • Cramer P, Bahlo J, Eichhorst B, Fischer K, Hallek M. Extramedullary manifestations of chronic lymphocytic leukaemia are not unusual. Leuk Res. 2014 Mar;38(3):284-5. doi: 10.1016/j.leukres.2013.11.015. Epub 2013 Dec 1. No abstract available.

    PMID: 24412156BACKGROUND
  • Goede V, Cramer P, Busch R, Bergmann M, Stauch M, Hopfinger G, Stilgenbauer S, Dohner H, Westermann A, Wendtner CM, Eichhorst B, Hallek M; German CLL Study Group. Interactions between comorbidity and treatment of chronic lymphocytic leukemia: results of German Chronic Lymphocytic Leukemia Study Group trials. Haematologica. 2014 Jun;99(6):1095-100. doi: 10.3324/haematol.2013.096792. Epub 2014 Feb 28.

    PMID: 24584349BACKGROUND
  • Sachanas S, Pangalis GA, Fink AM, Bahlo J, Fischer K, Levidou G, Kyrtsonis MC, Bartzi V, Vassilakopoulos TP, Kalpadakis C, Koulieris E, Moschogiannis M, Yiakoumis X, Tsirkinidis P, Angelopoulou MK, Eichhorst B, Hallek M. Small Lymphocytic Lymphoma: Analysis of Two Cohorts Including Patients in Clinical Trials of the German Chronic Lymphocytic Leukemia Study Group (GCLLSG) or in "Real-Life" Outside of Clinical Trials. Anticancer Res. 2019 May;39(5):2591-2598. doi: 10.21873/anticanres.13382.

    PMID: 31092457BACKGROUND
  • Eichhorst BF, Busch R, Stilgenbauer S, Stauch M, Bergmann MA, Ritgen M, Kranzhofer N, Rohrberg R, Soling U, Burkhard O, Westermann A, Goede V, Schweighofer CD, Fischer K, Fink AM, Wendtner CM, Brittinger G, Dohner H, Emmerich B, Hallek M; German CLL Study Group (GCLLSG). First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia. Blood. 2009 Oct 15;114(16):3382-91. doi: 10.1182/blood-2009-02-206185. Epub 2009 Jul 15.

MeSH Terms

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell

Interventions

fludarabineChlorambucil

Condition Hierarchy (Ancestors)

Leukemia, B-CellLeukemia, LymphoidLeukemiaNeoplasms by Histologic TypeNeoplasmsHematologic DiseasesHemic and Lymphatic DiseasesLymphoproliferative DisordersLymphatic DiseasesImmunoproliferative DisordersImmune System DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Nitrogen Mustard CompoundsMustard CompoundsHydrocarbons, HalogenatedHydrocarbonsOrganic Chemicals

Study Officials

  • Michael Hallek, MD

    Medizinische Universitaetsklinik I at the University of Cologne

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 6, 2005

First Posted

December 7, 2005

Study Start

September 1, 2003

Primary Completion

January 1, 2005

Study Completion

October 1, 2005

Last Updated

May 23, 2019

Record last verified: 2019-05

Locations